Loading...
XSWXSHLTN
Market cap48mUSD
Dec 20, Last price  
2.65CHF
1D
-3.28%
1Q
-14.24%
Jan 2017
-61.31%
Name

SHL Telemedicine Ltd

Chart & Performance

D1W1MN
XSWX:SHLTN chart
P/E
P/S
0.85
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
9.12%
Rev. gr., 5y
3.10%
Revenues
57m
-3.26%
103,052,00099,048,00062,848,00062,124,00044,554,00047,890,00050,252,00042,374,00026,938,00029,674,00039,976,00034,581,00040,548,00037,378,00048,863,00041,884,00040,164,00049,582,00058,998,00057,075,000
Net income
-7m
L+9,184.21%
-4,717,000-7,548,000-8,464,00023,375,0002,233,0005,377,0004,861,0003,997,000-7,304,0002,232,000829,000-16,635,000-11,096,0002,408,00010,141,0005,695,000278,000-14,110,000-76,000-7,056,000
CFO
-1m
L+1,949.32%
1,305,000-208,0001,800,000-1,801,000-7,550,0005,260,0003,008,000-3,503,0001,626,0002,815,000-3,117,0003,980,000-429,00011,844,00012,756,00010,850,0004,682,000185,000-73,000-1,496,000
Dividend
Apr 10, 20191 CHF/sh
Earnings
Feb 07, 2025

Profile

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. The company offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and collaboration agreement with the Hebrew University of Jerusalem and the Hadassah Medical Center to develop an artificial intelligence tool for predicting future life-threatening cardiac events based on 12 Lead ECG monitoring. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel.
IPO date
Nov 15, 2000
Employees
402
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
57,075
-3.26%
58,998
18.99%
49,582
23.45%
Cost of revenue
60,628
59,991
31,319
Unusual Expense (Income)
NOPBT
(3,553)
(993)
18,263
NOPBT Margin
36.83%
Operating Taxes
891
1,097
455
Tax Rate
2.49%
NOPAT
(4,444)
(2,090)
17,808
Net income
(7,056)
9,184.21%
(76)
-99.46%
(14,110)
-5,175.54%
Dividends
Dividend yield
Proceeds from repurchase of equity
20,246
1,953
37,462
BB yield
-17.91%
-0.91%
-13.96%
Debt
Debt current
4,595
4,432
4,139
Long-term debt
22,503
33,875
41,892
Deferred revenue
Other long-term liabilities
1,573
8,659
19,669
Net debt
701
15,575
13,969
Cash flow
Cash from operating activities
(1,496)
(73)
185
CAPEX
(1,289)
(6,904)
(3,258)
Cash from investing activities
(9,346)
(6,433)
(40,974)
Cash from financing activities
13,667
(2,281)
51,078
FCF
(1,749)
(362)
15,402
Balance
Cash
26,250
18,700
32,062
Long term investments
147
4,032
Excess cash
23,543
19,782
29,583
Stockholders' equity
(79,871)
(71,720)
(65,637)
Invested Capital
177,764
165,873
177,137
ROIC
12.46%
ROCE
15.89%
EV
Common stock shares outstanding
16,269
14,542
14,046
Price
6.95
-53.04%
14.80
-22.51%
19.10
60.50%
Market cap
113,070
-47.46%
215,222
-19.78%
268,279
114.63%
EV
116,704
234,399
286,159
EBITDA
4,119
6,141
23,645
EV/EBITDA
28.33
38.17
12.10
Interest
1,560
1,033
529
Interest/NOPBT
2.90%